Peter Pattison
@bsc_io
President, Interventional Oncology & Embolization at Boston Scientific, Peripheral Interventions @bsc_pi
Thank you, Interventional Radiologists! We are so grateful for your leadership and partnership. #SIOVegas #iRad @SphereVegas @SIO_Central
With 1 in 5 people around the world developing cancer in their lifetime BSC IO&E is grateful to provide our physician partners with more options to treat patients including #TheraSphere for #HCC, freezing cancer cells to reduce pain with the Visual-ICE #cryoablation system and…
Glioblastoma is the most common, most complex, and deadliest type of brain cancer. Only about 5% of GBM patients live more than five years, we are grateful to be exploring new treatment options for patients with this terrible disease through our Frontier Study. The Frontier Study…
The EuRECA study shows cryoablation is a safe and effective treatment for patients with RCC. Of 1,207 patients with T1a RCC, cryoablation demonstrated a PTE of 97.9%. Join us in celebrating the strength and resilience of cancer survivors this month and raising awareness about…
Great to share more #FrontierStudy news in #BrainCancerAwarenessMonth. We are excited to be expanding the trial to treat additional patients, including treatment of recurrent GBM tumors in other areas of the brain. Learn more about the expansion of the Frontier Study highlighted…
Heartfelt welcome to the @interaoncology team! Excited to add this technology to our BSC IO&E portfolio.
We’ve closed the acquisition of @InteraOncology, provider of the Intera 3000 Hepatic Artery Infusion Pump and floxuridine. We look forward to adding this technology to our portfolio and advancing treatment for patients with liver cancer.
@SIRspecialists Abstract of the year! First in man Y90 for recurrent GBM. Outstanding outcomes. Precision+imaging confirmation. Incredible MultiD collaboration. Thanks Roger Stupp! Onward! @bsc_io @cirsesociety @ASTRO_org @ESTRO_RT @ASCO @NorthwesternMed @NURadiology @SamMouli
NEW #FRONTIERstudy data presented by @SamMouli at #SIR25NASH Learn more about Frontier here: bit.ly/3WC5TqS #RecurrentGBM #ClinicalTrial #Glioblastoma #TheraSphereGBM @NorthwesternIR
IR is lighting up the city—and I’m here for it. Right in the heart of Broadway, a glowing tribute to what we do best: We stop the bleeding. We treat the cancer. We push medicine forward. Big thanks to @bostonsci for this. #SIR25NASH #ScrubsAndStetsons #VIRad
Preview one of SIR's Abstracts of the Year! Hear from @SamMouli on the Frontier Study: Preliminary Results of Safety and Feasibility of Yttrium-90 TheraSphere in Recurrent Glioblastoma. Read here: irq.sirweb.org/sirtoday/2025-… #TheraSphereGBM #Y90 #FRONTIERstudy #SIR2025…
In March we're featuring our Interventional Radiology and Image-Guided Therapy research. Sam Mouli works on two trials that use Yttirum-90 technology. @NMNeurology @NeurosurgeryNM @BrainTumorInst, @bostonsci @SIRspecialists @NM_Urology @sammouli #neurology #oncology #urology
March is #KidneyCancerAwarenessMonth. In 2024, over 80,000 new cases of kidney cancer were diagnosed. To advance treatment options, we're excited to highlight the EuRECA study, the largest prospective, real-world multicenter study focusing on cryoablation for the treatment of…
Interview with Dr. Riad Salem @riadsalemIR! We talk everything IR in HCC - Y90, his Legacy trial, & I push on why no SBRT (yet) in BCLC 😃. I learned a lot. Full video in replies on YouTube. Thank you, Riad!
Another highlight from #SIOVegas. Excited to be a part of this important trial treating patients with painful bone metastases. #ablation #cryoablation #VisualICE #ICEfx
Announcing the launch of SIO's second clinical trial, TRIBUTE: a multi-center study exploring outcomes of treating symptomatic, high-risk bone metastases with percutaneous ablation and palliative radiation therapy. conta.cc/3Q07pyG @VarianMedSys, Stryker and @bostonsci
Nice add on the @SphereVegas in Vegas, @bostonsci @SIO_Central !
Thanks for a great few days at #SIOVegas, here's to more collaboration and innovation in 2025 & beyond! #irad #interventionalradiology #interventionaloncology @SphereVegas